IL13 and atopic eczema: Although blocking this common receptor for the two ILs brings significant clinical benefits in atopic dermatitis, this benefit is not found for all pathologies in which IL-4 and IL-13 intervene, as a recent study suggests that IL-4/IL-13’s anti-inflammatory properties could be useful for inflammatory arthritis treatment [36].